Epigenetics Market Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

According to the latest market report published by Acute Market Reports, Inc. “Epigenetics Market By Product (Kits, Reagent, Enzymes, Instruments and Bioinformatics Tools), By Technology (DNA Methylation, Histone Modification and Other), By Application (Cancer, Metabolic Diseases, Immune Diseases, Cardiovascular Diseases and Other) – Growth, Future Prospects and Competitive Analysis, 2018 – 2026” The worldwide epigenetics market was valued at US$ 4.63 billion in 2017 and is anticipated to achieve US$ 16.50 billion by 2026, increasing to CAGR by 15.03 per cent from 2018 to 2026.  

Browse the full report at https://www.acutemarketreports.com/report/epigenetics-market

Market Insights

Epigenetics is a fairly new science in the wider sector of genetics, involving the study of the chemical modification of particular genes or gene-associated proteins. These epigenetic modifications do not require adjustments to the real DNA sequence. For the purpose of the research, the epigenetics market is segmented into product kinds such as kits (ChiP-Seq kits, full genome amplification kits, 5-HMC and 5-MC kits for evaluation and other epigenetics kits), reagents, enzymes (DNA-modifying enzymes, protein-modifying enzymes and RNA-modifying enzymes), instruments and bioinformatics tools. Currently, demand for kits is the highest on the market and is expected to show the fastest development in the market over the forecast period. Continuous progress in the design and accuracy of test kits, growing prevalence of distinct illnesses, broad accessibility of robust, easy-to-use and cost-effective kits, and increased use of epigenetic techniques in study laboratories are factors that catalyze general market growth.

The global market for epigenetics is segmented by technologies such as DNA methylation, histone modification and other techniques. DNA methylation is the most commonly accepted technology as it has excellent potential in the field of personalized drug development and comprehension of functional processes in complicated instances of disease. Epigenetics are used in cancer, metabolic diseases, immune illnesses, cardiovascular diseases and other regions. Cancer applications retained the biggest market share in baseline year 2017, as epigenetic changes are crucial for cell transformation to cancer and have excellent potential for manipulation in cancer detection, prevention and treatment.

North America, Latin America, Europe, Asia-Pacific, Middle East & Africa. Due to the high availability of research financing, North America will continue to dominate the Epigenetic industry. Europe is anticipated to hold the second biggest market share in the Epigenetic worldwide market. Growing public projects and an increasing number of biotechnological and biopharmaceutical businesses in APAC are also driving the epigenetics market in APAC.

Market Competition Assessment:

The epigenetics market is highly competitive owing to the presence of market players across geographies with investments in research activities. The market currently is dominated by few key manufacturers such as Abcam, Plc., Active Motif, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Diagenode, Inc., Illumina, Inc., Merck & Co., Inc., New England Biolabs Inc., Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Zymo Research Corp. and others.

By Product Type

• Kits
  • ChiP-Seq Kits
  • Whole-Genome Amplification Kits
  • 5-HMC and 5-MC Analysis Kits
  • Other Epigenetics Kits
• Reagents
• Enzymes
  • DNA-Modifying Enzymes
  • Protein-Modifying Enzymes
  • RNA-Modifying Enzymes
• Instruments
• Bioinformatics Tools

By Application Type

• Cancer
• Metabolic Diseases
• Immune Diseases
• Cardiovascular Diseases
• Others

By Technology Type

• DNA Methylation
• Histone Modification
• Other Techniques 

By Geography Segment

• North America
• Europe
• Asia Pacific (APAC)
• Middle East & Africa (MEA)
• Latin America